OTCMKTS:RCAR RenovaCare (RCAR) Stock Forecast, Price & News $0.0050 0.00 (0.00%) (As of 05/26/2023) Add Compare Share Share Today's Range$0.0050▼$0.005050-Day Range$0.00▼$0.1452-Week Range$0.00▼$0.45VolumeN/AAverage Volume934 shsMarket Capitalization$436,750.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest About RenovaCare (OTCMKTS:RCAR) StockRenovaCare, Inc. operates as a development stage company, which engages in the research, development, and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. Its flagship technology is the CellMist System, which is a treatment methodology for cell isolation for the regeneration of human skin cells and other tissues, and a solution sprayer device for delivering cells to the treatment area. The company was founded on July 14, 1983 and is headquartered in Scottsdale, AZ.Read More Receive RCAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter. Email Address RCAR Stock News HeadlinesApril 7, 2023 | americanbankingnews.comRenovaCare (OTCMKTS:RCAR) Shares Cross Below 50 Day Moving Average of $0.16September 27, 2022 | reuters.comRCAR.PK - RenovaCare Inc | Stock Price & Latest News | ReutersMay 30, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.August 16, 2022 | businesswire.comGlobal Burns Market Report to 2032 - Insight, Epidemiology and Forecasts - ResearchAndMarkets.com - Business WireAugust 13, 2022 | streetinsider.comForm 10-Q RenovaCare, Inc. For: Jun 30 - StreetInsider.comMay 13, 2022 | globenewswire.comLifshitz Law PLLC Announces Investigations of CorMedix Inc. (NASDAQGM: CRMD), FirstCash Holdings, Inc. (NASDAQ: FCFS), NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), Renovacare, Inc. (OTC-BB: RCAR) - GlobeNewswireMay 4, 2022 | globenewswire.comRenovaCare Announces Termination of StemCell Systems R&D Agreement - GlobeNewswireMay 3, 2022 | finance.yahoo.comRenovaCare Announces Termination of StemCell Systems R&D Agreement - Yahoo FinanceMay 30, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 3, 2022 | finance.yahoo.comRenovaCare Announces Termination of StemCell Systems R&D AgreementApril 22, 2022 | benzinga.comGlobal Skin Burns Market Insight, Epidemiology and Market Forecast 2019-2032 Featuring Pfizer, Avita Medical, Mallinckrodt & RenovaCare - BenzingaApril 19, 2022 | businesswire.comInsights on the Global Skin Burns Market (2019 to 2032) Includes Segmentation of 7 Major Markets - ResearchAndMarkets.com - Business WireApril 14, 2022 | stockhouse.com2022-04-14 | OTCPK:RCAR | Press Release | Renovacare Inc - StockhouseApril 14, 2022 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. is Investigating RenovaCare, Inc. - Benzinga - BenzingaApril 13, 2022 | globenewswire.comLifshitz Law Firm, PC Announces Investigations of ATI Physical Therapy, Inc. (NYSE: ATIP), DraftKings Inc. (NASDAQGS: DKNG), Electric Last Mile Solutions, Inc., and Renovacare, Inc. (OTC-BB: RCAR) - GlobeNewswireMarch 25, 2022 | stockhouse.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating RenovaCare, Inc. - StockhouseMarch 24, 2022 | seekingalpha.comRenovaCare trims management team amid cost cutting measuresMarch 24, 2022 | globenewswire.comRenovaCare Announces Management Changes - GlobeNewswireMarch 24, 2022 | finance.yahoo.comRenovaCare Announces Management ChangesMarch 10, 2022 | finance.yahoo.comIris Energy Limited Announces Monthly Investor Update for February 2022 - Yahoo FinanceMarch 10, 2022 | globenewswire.comRenovaCare Provides Clinical and Corporate Update - GlobeNewswireMarch 9, 2022 | finance.yahoo.comWISeKey’s WISeID Platform Helps Individuals and Companies Reduce Cybersecurity Risks - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comWorldwide Continuous Renal Replacement Therapy Industry to 2027 - Ongoing Research and Development in Continuous Renal Replacement Therapy Presents Opportunities - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comVelocityEHS Acquires Job Analysis & Return-to-Work Management Technology Solutions from MyAbilities - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comMovement Industries Corporation Appoints New CFO and Increases Revenues by Approximately 84% over Previous Quarter - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comThe opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035, claims Roots Analysis - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comCanasil Review of Candy Vein Drill Results With Up To 8,445 g/t AgEq* x Metres True Width x Grade Suggests High Potential at the Nora Silver and Gold Project, Durango, Mexico - Yahoo FinanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RCAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter. Email Address RCAR Company Calendar Today5/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RCAR CUSIPN/A CIK1016708 Webwww.renovacareinc.com Phone(888) 398-0202FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-5,071.08% Return on Assets-251.03% Debt Debt-to-Equity RatioN/A Current Ratio0.62 Quick Ratio0.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares87,350,000Free Float86,601,000Market Cap$436,750.00 OptionableNot Optionable Beta1.37 Key ExecutivesHarmel S. RayatChairman, President, CEO, CFO & SecretaryRoger Esteban-VivesVice President-Research & Product DevelopmentRobin A. RobinsonChief Scientific OfficerJo Ellen SchweinleChief Medical OfficerRodney L. SparksVice President-Intellectual Property & LicensingKey CompetitorsHypertension DiagnosticsOTCMKTS:HDIIH-CYTEOTCMKTS:HCYTDRegenicinOTCMKTS:RGINQuantRx BiomedicalOTCMKTS:QTXBPresbiaOTCMKTS:LENSFView All Competitors RCAR Stock - Frequently Asked Questions How have RCAR shares performed in 2023? RenovaCare's stock was trading at $0.0201 on January 1st, 2023. Since then, RCAR stock has decreased by 75.1% and is now trading at $0.0050. View the best growth stocks for 2023 here. What other stocks do shareholders of RenovaCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other RenovaCare investors own include Brainstorm Cell Therapeutics (BCLI), ReNeuron Group (RENE), Fulcrum Therapeutics (FULC), SCYNEXIS (SCYX), Teva Pharmaceutical Industries (TEVA), Akebia Therapeutics (AKBA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Barrick Gold (GOLD) and Iovance Biotherapeutics (IOVA). What is RenovaCare's stock symbol? RenovaCare trades on the OTCMKTS under the ticker symbol "RCAR." How do I buy shares of RenovaCare? Shares of RCAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is RenovaCare's stock price today? One share of RCAR stock can currently be purchased for approximately $0.01. How much money does RenovaCare make? RenovaCare (OTCMKTS:RCAR) has a market capitalization of $436,750.00. The biotechnology company earns $-4,470,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. How can I contact RenovaCare? RenovaCare's mailing address is 4 BECKER FARM ROAD SUITE 105, ROSELAND NJ, 07068. The official website for the company is www.renovacareinc.com. The biotechnology company can be reached via phone at (888) 398-0202. This page (OTCMKTS:RCAR) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovaCare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.